ADT
55
25
PM
52
-4
C
37
-2
HCA
55
2
CTAS
64
2
TGNA
58
4
AMG
44
-3
KR
50
10
AVGO
57
-14
OMC
53
3
DE
29
-3
TROW
48
-2
PRU
50
2
GPS
57
-3
AKAM
48
-11
IPG
42
-2
URBN
70
4
OXY
41
4
NVDA
60
-5
RIG
28
2
ADT
55
25
PM
52
-4
C
37
-2
HCA
55
2
CTAS
64
2
TGNA
58
4
AMG
44
-3
KR
50
10
AVGO
57
-14
OMC
53
3
DE
29
-3
TROW
48
-2
PRU
50
2
GPS
57
-3
AKAM
48
-11
IPG
42
-2
URBN
70
4
OXY
41
4
NVDA
60
-5
RIG
28
2
Financhill
Back

Realty Income Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Sell
37

O
Realty Income

Last Price:
53.15
Seasonality Move:
2.22%
Sell
43

RARE
Ultragenyx Pharmaceutical

Last Price:
39.58
Seasonality Move:
3.65%
Sell
37
Realty Income (O) is a Sell

Is Realty Income a Buy, Sell or Hold?

  • The current Realty Income [O] share price is $53.15. The Score for O is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
  • O is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
43
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $39.60. The Score for RARE is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

O Stock Price Chart

What is Realty Income's stock price today?

  • The Realty Income share price today is $53.15
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and O is experiencing buying pressure, which is a positive indicator for future bullish movement.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $39.60
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing buying pressure, which is a positive indicator for future bullish movement.

O Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.16 Sell
Relative Strength Index (14 RSI): 48.58 Sell
Chaikin Money Flow: 11312568 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (52.18 - 54.38) Sell
Bollinger Bands (100): (52.03 - 54.27) Sell

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.73 Sell
Relative Strength Index (14 RSI): 45.77 Sell
Chaikin Money Flow: 722527 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (38.99 - 42.29) Sell
Bollinger Bands (100): (41.03 - 48.83) Sell

O Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 52.98 Buy
20-day SMA: 52.9 Buy
50-day SMA: 53.5 Sell
200-day SMA: 53.33 Sell
8-day EMA: 53.1 Buy
20-day EMA: 53.23 Sell
50-day EMA: 53.4 Sell
200-day EMA: 54.58 Sell

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 40.38 Sell
20-day SMA: 40.41 Sell
50-day SMA: 41.94 Sell
200-day SMA: 42.46 Sell
8-day EMA: 39.76 Sell
20-day EMA: 40.54 Sell
50-day EMA: 42.03 Sell
200-day EMA: 43.46 Sell

Realty Income Earnings Growth & O Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.07 per share, an increase next quarter of $0.01 per share, an increase this year of $0.20 per share, and an increase next year of $0.19 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.49 per share, an increase next quarter of $0.01 per share, an increase this year of $0.90 per share, and an increase next year of $1.07 per share.

Realty Income Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):